CareDx Company Profile (NASDAQ:CDNA)

About CareDx

CareDx logoCareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CDNA
  • CUSIP:
Key Metrics:
  • Previous Close: $2.25
  • 50 Day Moving Average: $2.46
  • 200 Day Moving Average: $3.50
  • 52-Week Range: $2.20 - $6.08
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.41
  • P/E Growth: -0.12
  • Market Cap: $47.87M
  • Outstanding Shares: 21,277,000
  • Beta: 0.73
Profitability:
  • Net Margins: -78.62%
  • Return on Equity: -57.94%
  • Return on Assets: -22.51%
Debt:
  • Debt-to-Equity Ratio: 0.23%
  • Current Ratio: 0.89%
  • Quick Ratio: 0.70%
Additional Links:
Companies Related to CareDx:

Analyst Ratings

Consensus Ratings for CareDx (NASDAQ:CDNA) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.33 (270.37% upside)

Analysts' Ratings History for CareDx (NASDAQ:CDNA)
Show:
DateFirmActionRatingPrice TargetDetails
6/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$6.00View Rating Details
6/14/2016Leerink SwannReiterated RatingBuyView Rating Details
6/14/2016MizuhoBoost Price TargetBuy$8.00 -> $12.00View Rating Details
2/9/2016Janney Montgomery ScottInitiated CoverageBuy -> Buy$12.00View Rating Details
11/18/2015Craig HallumBoost Price TargetBuy$10.00 -> $13.00View Rating Details
9/28/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for CareDx (NASDAQ:CDNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/22/2017        
11/10/2016Q3 2016($0.25)($0.15)$11.50 million$12.48 millionViewListenView Earnings Details
8/10/2016Q216($0.28)($0.29)$10.42 million$10.70 millionViewListenView Earnings Details
5/6/2016Q1($0.31)($0.37)$6.97 million$6.60 millionViewN/AView Earnings Details
3/24/2016Q415($0.34)($0.40)$7.44 million$6.60 millionViewListenView Earnings Details
11/11/2015Q315($0.25)($0.29)$7.34 million$7.15 millionViewListenView Earnings Details
8/10/2015Q215($0.18)($0.27)$7.28 million$7.13 millionViewListenView Earnings Details
5/12/2015Q115($0.18)($0.19)$6.82 million$7.22 millionViewListenView Earnings Details
11/10/2014Q314($0.13)$0.12$6.60 million$6.65 millionViewN/AView Earnings Details
8/27/2014Q2 14($0.13)$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CareDx (NASDAQ:CDNA)
Current Year EPS Consensus Estimate: $-0.96 EPS
Next Year EPS Consensus Estimate: $-0.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.32)($0.29)($0.31)
Q2 20162($0.30)($0.21)($0.26)
Q3 20162($0.22)($0.22)($0.22)
Q4 20162($0.22)($0.22)($0.22)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for CareDx (NASDAQ:CDNA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CareDx (NASDAQ:CDNA)
Insider Ownership Percentage: 13.33%
Institutional Ownership Percentage: 38.35%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Neil GagnonMajor ShareholderBuy178,686$4.00$714,744.00View SEC Filing  
4/14/2016Neil GagnonMajor ShareholderBuy93,240$4.02$374,824.80View SEC Filing  
10/21/2015Neil Gagnonmajor shareholderBuy1,431$4.99$7,140.69View SEC Filing  
10/20/2015Neil GagnonMajor ShareholderBuy1,347$4.92$6,627.24View SEC Filing  
9/29/2015Neil Gagnonmajor shareholderBuy6,332$6.10$38,625.20View SEC Filing  
9/4/2015Neil GagnonMajor ShareholderBuy69,383$6.95$482,211.85View SEC Filing  
6/5/2015Neil GagnonMajor ShareholderBuy6,500$5.69$36,985.00View SEC Filing  
6/1/2015Peter MaagCEOBuy2,000$4.84$9,680.00View SEC Filing  
4/17/2015Neil GagnonMajor ShareholderBuy13,051$5.34$69,692.34View SEC Filing  
3/20/2015Neil GagnonMajor ShareholderBuy6,324$6.35$40,157.40View SEC Filing  
2/27/2015Neil GagnonMajor ShareholderBuy4,270$6.03$25,748.10View SEC Filing  
2/6/2015Neil GagnonMajor ShareholderBuy4,586$7.20$33,019.20View SEC Filing  
2/5/2015Neil GagnonMajor ShareholderBuy121,587$7.10$863,267.70View SEC Filing  
2/4/2015Neil GagnonMajor ShareholderBuy31,991$7.00$223,937.00View SEC Filing  
2/3/2015Neil GagnonMajor ShareholderBuy23,558$7.03$165,612.74View SEC Filing  
2/2/2015Neil GagnonMajor ShareholderBuy3,620$7.05$25,521.00View SEC Filing  
1/29/2015Neil GagnonMajor ShareholderBuy15,395$7.04$108,380.80View SEC Filing  
1/27/2015Neil GagnonMajor ShareholderBuy84,720$7.00$593,040.00View SEC Filing  
1/22/2015Neil GagnonMajor ShareholderBuy48,670$7.13$347,017.10View SEC Filing  
1/20/2015Neil GagnonMajor ShareholderBuy16,192$6.66$107,838.72View SEC Filing  
1/15/2015Neil GagnonMajor ShareholderBuy39,109$6.43$251,470.87View SEC Filing  
1/14/2015Neil GagnonMajor ShareholderBuy122,319$7.07$864,795.33View SEC Filing  
7/22/2014Ken LudlumCFOBuy7,000$10.00$70,000.00View SEC Filing  
7/22/2014Michael GoldbergDirectorBuy25,000$10.00$250,000.00View SEC Filing  
7/22/2014Perkins Caufield & Bye KleinerMajor ShareholderBuy52,770$10.00$527,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CareDx (NASDAQ:CDNA)
DateHeadline
4-traders.com logoCAREDX, INC. (NASDAQ:CDNA) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:CDNA)
www.4-traders.com - January 25 at 5:18 PM
us.rd.yahoo.com logo4:02 pm CareDx indicated higher after issuing press release highlighting agreement with Illumina (ILMN (NASDAQ:CDNA)
us.rd.yahoo.com - January 25 at 2:49 AM
streetinsider.com logoCareDx (CDNA) Signs Agreement to Acquire SBT Resolver HLA Typing Products from Illumina (NASDAQ:CDNA)
www.streetinsider.com - January 24 at 4:47 PM
finance.yahoo.com logoCareDx to acquire SBT Resolver™ HLA Typing Products from Illumina (NASDAQ:CDNA)
finance.yahoo.com - January 24 at 4:47 PM
biz.yahoo.com logoCAREDX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat (NASDAQ:CDNA)
biz.yahoo.com - January 23 at 4:31 PM
News IconCareDx Inc CDNA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CDNA)
www.bioportfolio.com - January 7 at 4:45 PM
biz.yahoo.com logoCAREDX, INC. Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:CDNA)
biz.yahoo.com - December 23 at 9:27 PM
News IconCareDx, Inc. CDNA Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:CDNA)
www.bioportfolio.com - December 21 at 2:47 AM
capitalcube.com logoETFs with exposure to CareDx, Inc. : December 8, 2016 (NASDAQ:CDNA)
www.capitalcube.com - December 8 at 5:00 PM
4-traders.com logoCareDx : CMS Announces CLFS for 2017 CareDxs AlloMap Reimbursement Updated; Rate to Remain at $2,821 (NASDAQ:CDNA)
www.4-traders.com - November 24 at 4:11 PM
finance.yahoo.com logoCMS Announces CLFS for 2017 – CareDx’s AlloMap Reimbursement Updated; Rate to Remain at $2,821 (NASDAQ:CDNA)
finance.yahoo.com - November 21 at 10:08 PM
globenewswire.com logoAlloSure Detects Active Rejection in Kidney Transplant Patients (NASDAQ:CDNA)
globenewswire.com - November 18 at 8:27 PM
News IconCareDx, Inc. CDNA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CDNA)
www.bioportfolio.com - November 17 at 3:21 PM
einnews.com logoCareDx and Leading Transplant Clinicians to Present AlloSure® DART Data During Kidney Week at the American Society of Nephrology Meeting in Chicago (NASDAQ:CDNA)
energy.einnews.com - November 16 at 9:49 PM
capitalcube.com logoETFs with exposure to CareDx, Inc. : November 16, 2016 (NASDAQ:CDNA)
www.capitalcube.com - November 16 at 4:04 PM
biz.yahoo.com logoCAREDX, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CDNA)
biz.yahoo.com - November 15 at 10:43 AM
capitalcube.com logoCareDx, Inc. :CDNA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 (NASDAQ:CDNA)
www.capitalcube.com - November 11 at 1:33 PM
finance.yahoo.com logoEdited Transcript of CDNA earnings conference call or presentation 9-Nov-16 9:30pm GMT (NASDAQ:CDNA)
finance.yahoo.com - November 10 at 10:07 PM
einnews.com logoCareDx Reports Third Quarter 2016 Financial Results (NASDAQ:CDNA)
www.einnews.com - November 10 at 12:29 PM
sg.finance.yahoo.com logoCareDx reports 3Q loss (NASDAQ:CDNA)
sg.finance.yahoo.com - November 9 at 8:51 PM
biz.yahoo.com logoQ3 2016 CareDx Inc Earnings Release - After Market Close (NASDAQ:CDNA)
biz.yahoo.com - November 9 at 1:07 PM
finance.yahoo.com logoCareDx to Participate in Upcoming Investor Conferences (NASDAQ:CDNA)
finance.yahoo.com - November 8 at 9:39 PM
finance.yahoo.com logoCareDx to present AlloSure® data at AMP in Charlotte, NC (NASDAQ:CDNA)
finance.yahoo.com - November 3 at 9:09 PM
nasdaq.com logoCareDx to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 9, 201 (NASDAQ:CDNA)
www.nasdaq.com - October 27 at 9:41 PM
finance.yahoo.com logoCareDx to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 9, 2016 (NASDAQ:CDNA)
finance.yahoo.com - October 27 at 4:26 PM
finance.yahoo.com logoHeart Transplant Patients Warn That CMS Decision Could Deprive Them Of Needed Care (NASDAQ:CDNA)
finance.yahoo.com - October 26 at 11:13 AM
streetinsider.com logoCareDx (CDNA) Makes First Olerup QTYPE Commercial Sale (NASDAQ:CDNA)
www.streetinsider.com - October 25 at 9:25 PM
finance.yahoo.com logoCareDx Announces First Commercial Sale of Olerup QTYPE (NASDAQ:CDNA)
finance.yahoo.com - October 24 at 4:03 PM
finance.yahoo.com logoCareDx’s AlloSure® Featured in The Journal of Molecular Diagnostics (NASDAQ:CDNA)
finance.yahoo.com - October 13 at 4:03 PM
publicnow.com logoAlloSure® Validation Highlighted by Journal of Molecular Diagnostics Press Release (NASDAQ:CDNA)
www.publicnow.com - October 10 at 3:58 PM
finance.yahoo.com logoCMS Proposal Threatens Availability Of Standard Of Care Blood Test To Heart Transplant Patients (NASDAQ:CDNA)
finance.yahoo.com - October 3 at 8:56 AM
4-traders.com logoCareDx Launches Olerup QTYPE® at ASHI (NASDAQ:CDNA)
www.4-traders.com - September 29 at 9:01 AM
streetinsider.com logoCareDx (CDNA) Announces Launch of Olerup QTYPE (NASDAQ:CDNA)
www.streetinsider.com - September 29 at 9:01 AM
4-traders.com logoCareDx : Announces Closing of Public Offering of Common Stock (NASDAQ:CDNA)
www.4-traders.com - September 28 at 4:00 PM
globenewswire.com logoCareDx Announces Closing of Public Offering of Common Stock (NASDAQ:CDNA)
globenewswire.com - September 27 at 8:43 AM
capitalcube.com logoETF’s with exposure to CareDx, Inc. : September 26, 2016 (NASDAQ:CDNA)
www.capitalcube.com - September 26 at 4:22 PM
benzinga.com logoMid-Afternoon Market Update: Dow Surges 125 Points; FedEx Shares Jump Following Upbeat Earnings (NASDAQ:CDNA)
www.benzinga.com - September 23 at 9:18 AM
streetinsider.com logoCareDx (CDNA) Prices 2.25M Common Stock Offering at $4/Share (NASDAQ:CDNA)
www.streetinsider.com - September 23 at 9:18 AM
4-traders.com logoCareDx : Announces Pricing of Public Offering of Common Stock (NASDAQ:CDNA)
www.4-traders.com - September 23 at 9:18 AM
publicnow.com logoCareDx Announces Pricing of Public Offering of Common Stock (NASDAQ:CDNA)
www.publicnow.com - September 23 at 9:18 AM
finance.yahoo.com logoCareDx Announces Proposed Public Offering of Common Stock (NASDAQ:CDNA)
finance.yahoo.com - September 21 at 8:08 AM
finance.yahoo.com logoCAREDX, INC. Financials (NASDAQ:CDNA)
finance.yahoo.com - August 27 at 3:59 PM
4-traders.com logoCareDx : Reports Status of Form 10-Q (NASDAQ:CDNA)
www.4-traders.com - August 17 at 12:13 PM
finance.yahoo.com logoCareDx Reports Status of Form 10-Q (NASDAQ:CDNA)
finance.yahoo.com - August 16 at 10:26 AM
finance.yahoo.com logo8:04 am CareDx files w/ the SEC a Form 12b-25 for an extension of time for the filing of its Form 10-Q b/c it needs additional time to complete the final review of its financial statements and other disclosures (NASDAQ:CDNA)
finance.yahoo.com - August 16 at 10:26 AM
biz.yahoo.com logoCAREDX, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CDNA)
biz.yahoo.com - August 16 at 10:26 AM
capitalcube.com logoCareDx, Inc. :CDNA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:CDNA)
www.capitalcube.com - August 12 at 12:41 PM
publicnow.com logoCareDx Reports Preliminary Second Quarter 2016 Financial Results (NASDAQ:CDNA)
www.publicnow.com - August 11 at 12:27 PM
sg.finance.yahoo.com logoCareDx reports 2Q loss (NASDAQ:CDNA)
sg.finance.yahoo.com - August 10 at 9:42 PM
biz.yahoo.com logoQ2 2016 CareDx Inc Earnings Release - After Market Close (NASDAQ:CDNA)
biz.yahoo.com - August 10 at 11:43 AM

Social

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Where is CareDx's stock going? Where will CareDx's stock price be in 2017?

3 equities research analysts have issued 1 year target prices for CareDx's shares. Their predictions range from $6.00 to $12.00. On average, they anticipate CareDx's stock price to reach $8.33 in the next year.

When will CareDx announce their earnings?

CareDx is scheduled to release their next quarterly earnings announcement on Wednesday, March, 22nd 2017.

Who owns CareDx stock?

CareDx's stock is owned by a number of of institutional and retail investors. Top institutional investors include Highland Capital Management LP (7.59%), Paragon Associates & Paragon Associates II Joint Venture (6.93%), Royce & Associates LP (2.00%) and Gabelli Funds LLC (0.24%). Company insiders that own CareDx stock include Neil Gagnon and Peter Maag.

Who sold CareDx stock? Who is selling CareDx stock?

CareDx's stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC.

Who bought CareDx stock? Who is buying CareDx stock?

CareDx's stock was acquired by a variety of institutional investors in the last quarter, including Royce & Associates LP and Highland Capital Management LP. Company insiders that have bought CareDx stock in the last two years include Neil Gagnon and Peter Maag.

How do I buy CareDx stock?

Shares of CareDx can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CareDx stock cost?

One share of CareDx stock can currently be purchased for approximately $2.25.

CareDx (NASDAQ:CDNA) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for CareDx (NASDAQ:CDNA)

Earnings History Chart

Earnings by Quarter for CareDx (NASDAQ:CDNA)

Dividend History Chart

Dividend Payments by Quarter for CareDx (NASDAQ:CDNA)

Last Updated on 2/22/2017 by MarketBeat.com Staff